STOCK TITAN

[Form 4] Twist Bioscience Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Karpus Management, Inc. filed Amendment No. 2 to Schedule 13G for Eureka Acquisition Corp (EURKU) covering the event date 30 June 2025.

The registered investment adviser now reports beneficial ownership of 327,400 common shares, representing 4.28 % of the outstanding class. Karpus holds sole voting and dispositive power over the entire position and no shared power with other parties. Because the stake has fallen below the 5 % threshold, Karpus is no longer deemed a 5 % beneficial owner under Section 13(d) of the Exchange Act but remains subject to Rule 13d-1(b) reporting requirements.

The shares are held in discretionary advisory accounts managed by Karpus, which operates independently of its parent, City of London Investment Group plc, through established informational barriers. The filing affirms that the securities were acquired in the ordinary course of business and not for the purpose of influencing control of the issuer.

Implications for investors: the reduction slightly increases EURKU’s public float and removes Karpus from the list of significant 5 % holders, potentially diminishing expectations of activist involvement. Nonetheless, a 4.28 % position remains a meaningful minority interest that could provide ongoing institutional oversight.

Karpus Management, Inc. ha presentato la Modifica n. 2 al Programma 13G per Eureka Acquisition Corp (EURKU) relativa alla data dell'evento 30 giugno 2025.

L'investment adviser registrato riporta ora una detenzione effettiva di 327.400 azioni ordinarie, che rappresentano il 4,28% della classe in circolazione. Karpus detiene il pieno potere di voto e di disposizione sull'intera posizione e nessun potere condiviso con altre parti. Poiché la partecipazione è scesa al di sotto della soglia del 5%, Karpus non è più considerato un detentore effettivo del 5% ai sensi della Sezione 13(d) del Securities Exchange Act, ma rimane soggetto agli obblighi di segnalazione previsti dalla Regola 13d-1(b).

Le azioni sono detenute in conti discrezionali di consulenza gestiti da Karpus, che opera in modo indipendente dalla sua controllante, City of London Investment Group plc, attraverso barriere informative stabilite. La comunicazione conferma che i titoli sono stati acquisiti nell'ordinaria attività commerciale e non con l'obiettivo di influenzare il controllo dell'emittente.

Implicazioni per gli investitori: la riduzione aumenta leggermente il flottante pubblico di EURKU ed esclude Karpus dalla lista dei detentori significativi del 5%, potenzialmente riducendo le aspettative di un coinvolgimento attivista. Tuttavia, una posizione del 4,28% resta una quota minoritaria significativa che potrebbe garantire una supervisione istituzionale continua.

Karpus Management, Inc. presentó la Enmienda No. 2 al Schedule 13G para Eureka Acquisition Corp (EURKU) correspondiente a la fecha del evento 30 de junio de 2025.

El asesor de inversiones registrado ahora reporta una propiedad beneficiosa de 327,400 acciones comunes, que representan el 4.28 % de la clase en circulación. Karpus tiene poder exclusivo de voto y disposición sobre toda la posición y ningún poder compartido con otras partes. Debido a que la participación ha caído por debajo del umbral del 5 %, Karpus ya no se considera un propietario beneficiario del 5 % según la Sección 13(d) de la Ley de Bolsa, pero sigue sujeto a los requisitos de reporte de la Regla 13d-1(b).

Las acciones se mantienen en cuentas discrecionales de asesoría gestionadas por Karpus, que opera de forma independiente de su matriz, City of London Investment Group plc, mediante barreras informativas establecidas. La presentación confirma que los valores fueron adquiridos en el curso ordinario del negocio y no con el propósito de influir en el control del emisor.

Implicaciones para los inversores: la reducción aumenta ligeramente el flotante público de EURKU y elimina a Karpus de la lista de titulares significativos del 5 %, lo que podría disminuir las expectativas de participación activista. No obstante, una posición del 4.28 % sigue siendo una participación minoritaria significativa que podría proporcionar supervisión institucional continua.

Karpus Management, Inc.는 2025년 6월 30일 기준 이벤트에 대해 Eureka Acquisition Corp (EURKU)의 Schedule 13G 수정안 2호를 제출했습니다.

등록된 투자 자문사는 현재 327,400주 보통주에 대한 실질 소유권을 보고하며, 이는 발행 주식의 4.28%에 해당합니다. Karpus는 전체 지분에 대해 단독 의결권 및 처분권을 보유하고 있으며, 다른 당사자와는 공동 권한이 없습니다. 지분이 5% 기준선 아래로 떨어짐에 따라 Karpus는 증권거래법 섹션 13(d)에 따른 5% 실소유주로 간주되지 않으나, 여전히 규칙 13d-1(b)에 따른 보고 의무는 유지됩니다.

주식은 Karpus가 관리하는 재량 자문 계좌에 보유되어 있으며, Karpus는 모회사인 City of London Investment Group plc와는 독립적으로 정보 장벽을 통해 운영됩니다. 제출 서류는 해당 증권이 통상적인 사업 활동 중에 취득되었으며 발행사 지배권에 영향을 미치기 위한 목적이 아님을 확인합니다.

투자자에 대한 시사점: 이번 감소로 인해 EURKU의 공개 유통 주식 수가 소폭 증가하고 Karpus가 5% 이상의 주요 보유자 명단에서 제외되어 행동주의자 참여에 대한 기대가 다소 줄어들 수 있습니다. 그럼에도 불구하고 4.28%의 지분은 계속해서 의미 있는 소수 지분으로서 지속적인 기관 감시 역할을 할 수 있습니다.

Karpus Management, Inc. a déposé l'Amendement n° 2 au Schedule 13G concernant Eureka Acquisition Corp (EURKU) pour la date de l'événement du 30 juin 2025.

Le conseiller en investissement enregistré déclare désormais une possession bénéficiaire de 327 400 actions ordinaires, représentant 4,28 % de la classe en circulation. Karpus détient le pouvoir exclusif de vote et de disposition sur l'intégralité de la position et aucun pouvoir partagé avec d'autres parties. Comme la participation est passée sous le seuil de 5 %, Karpus n'est plus considéré comme un détenteur bénéficiaire de 5 % selon la Section 13(d) du Exchange Act, mais reste soumis aux obligations de déclaration de la Règle 13d-1(b).

Les actions sont détenues dans des comptes-conseils discrétionnaires gérés par Karpus, qui opère de manière indépendante de sa société mère, City of London Investment Group plc, grâce à des barrières informationnelles établies. Le dépôt confirme que les titres ont été acquis dans le cours normal des affaires et non dans le but d'influencer le contrôle de l'émetteur.

Implications pour les investisseurs : cette réduction augmente légèrement le flottant public d’EURKU et retire Karpus de la liste des détenteurs significatifs de 5 %, ce qui pourrait diminuer les attentes d’une implication activiste. Néanmoins, une position de 4,28 % reste une participation minoritaire significative pouvant assurer une surveillance institutionnelle continue.

Karpus Management, Inc. hat die Änderung Nr. 2 zum Schedule 13G für Eureka Acquisition Corp (EURKU) eingereicht, bezogen auf das Ereignisdatum 30. Juni 2025.

Der registrierte Anlageberater meldet nun wirtschaftliches Eigentum an 327.400 Stammaktien, was 4,28 % der ausstehenden Aktienklasse entspricht. Karpus hält alleinige Stimm- und Verfügungsgewalt über die gesamte Position und keine geteilte Macht mit anderen Parteien. Da der Anteil unter die 5%-Schwelle gefallen ist, gilt Karpus nicht mehr als 5%-Eigentümer nach Abschnitt 13(d) des Börsengesetzes, unterliegt jedoch weiterhin den Meldepflichten gemäß Regel 13d-1(b).

Die Aktien werden in diskretionären Beratungsdepots gehalten, die von Karpus verwaltet werden, das unabhängig von seiner Muttergesellschaft City of London Investment Group plc durch etablierte Informationsbarrieren operiert. Die Einreichung bestätigt, dass die Wertpapiere im normalen Geschäftsverlauf erworben wurden und nicht mit dem Ziel, die Kontrolle über den Emittenten zu beeinflussen.

Auswirkungen für Investoren: Die Reduzierung erhöht leicht den Streubesitz von EURKU und entfernt Karpus von der Liste bedeutender 5%-Anteilseigner, was die Erwartungen an aktivistische Eingriffe verringern könnte. Dennoch bleibt eine Position von 4,28 % ein bedeutendes Minderheitsinteresse, das eine fortlaufende institutionelle Überwachung ermöglichen kann.

Positive
  • Enhanced transparency: Updated 13G/A provides investors with clear, timely data on institutional ownership.
Negative
  • Stake falls below 5 %: Karpus’ reduction removes a significant holder, hinting at recent sales and slightly diluting concentrated ownership.

Insights

TL;DR – Karpus drops to 4.28 %, exiting 5 % holder status; governance impact modest.

The amendment shows Karpus’ stake now sits below the critical 5 % reporting threshold, signalling recent selling. While this reduces the probability of an activist campaign, Karpus retains sole voting control over a still-material block that can influence routine matters. The certification that shares are held in the ordinary course, plus independent control from its parent CLIG, further limits governance implications. Overall, the filing is more administrative than strategic but worth noting for ownership-structure tracking.

TL;DR – Slightly negative signal: institutional holder trims position, float rises.

For a SPAC like EURKU, concentrated holdings can support price stability. Karpus’ reduction to 4.28 % adds incremental liquidity but may introduce mild selling pressure if the exit continues. Absence of intent to influence control suggests no near-term catalyst from this shareholder. Market impact should be limited unless further divestiture emerges.

Karpus Management, Inc. ha presentato la Modifica n. 2 al Programma 13G per Eureka Acquisition Corp (EURKU) relativa alla data dell'evento 30 giugno 2025.

L'investment adviser registrato riporta ora una detenzione effettiva di 327.400 azioni ordinarie, che rappresentano il 4,28% della classe in circolazione. Karpus detiene il pieno potere di voto e di disposizione sull'intera posizione e nessun potere condiviso con altre parti. Poiché la partecipazione è scesa al di sotto della soglia del 5%, Karpus non è più considerato un detentore effettivo del 5% ai sensi della Sezione 13(d) del Securities Exchange Act, ma rimane soggetto agli obblighi di segnalazione previsti dalla Regola 13d-1(b).

Le azioni sono detenute in conti discrezionali di consulenza gestiti da Karpus, che opera in modo indipendente dalla sua controllante, City of London Investment Group plc, attraverso barriere informative stabilite. La comunicazione conferma che i titoli sono stati acquisiti nell'ordinaria attività commerciale e non con l'obiettivo di influenzare il controllo dell'emittente.

Implicazioni per gli investitori: la riduzione aumenta leggermente il flottante pubblico di EURKU ed esclude Karpus dalla lista dei detentori significativi del 5%, potenzialmente riducendo le aspettative di un coinvolgimento attivista. Tuttavia, una posizione del 4,28% resta una quota minoritaria significativa che potrebbe garantire una supervisione istituzionale continua.

Karpus Management, Inc. presentó la Enmienda No. 2 al Schedule 13G para Eureka Acquisition Corp (EURKU) correspondiente a la fecha del evento 30 de junio de 2025.

El asesor de inversiones registrado ahora reporta una propiedad beneficiosa de 327,400 acciones comunes, que representan el 4.28 % de la clase en circulación. Karpus tiene poder exclusivo de voto y disposición sobre toda la posición y ningún poder compartido con otras partes. Debido a que la participación ha caído por debajo del umbral del 5 %, Karpus ya no se considera un propietario beneficiario del 5 % según la Sección 13(d) de la Ley de Bolsa, pero sigue sujeto a los requisitos de reporte de la Regla 13d-1(b).

Las acciones se mantienen en cuentas discrecionales de asesoría gestionadas por Karpus, que opera de forma independiente de su matriz, City of London Investment Group plc, mediante barreras informativas establecidas. La presentación confirma que los valores fueron adquiridos en el curso ordinario del negocio y no con el propósito de influir en el control del emisor.

Implicaciones para los inversores: la reducción aumenta ligeramente el flotante público de EURKU y elimina a Karpus de la lista de titulares significativos del 5 %, lo que podría disminuir las expectativas de participación activista. No obstante, una posición del 4.28 % sigue siendo una participación minoritaria significativa que podría proporcionar supervisión institucional continua.

Karpus Management, Inc.는 2025년 6월 30일 기준 이벤트에 대해 Eureka Acquisition Corp (EURKU)의 Schedule 13G 수정안 2호를 제출했습니다.

등록된 투자 자문사는 현재 327,400주 보통주에 대한 실질 소유권을 보고하며, 이는 발행 주식의 4.28%에 해당합니다. Karpus는 전체 지분에 대해 단독 의결권 및 처분권을 보유하고 있으며, 다른 당사자와는 공동 권한이 없습니다. 지분이 5% 기준선 아래로 떨어짐에 따라 Karpus는 증권거래법 섹션 13(d)에 따른 5% 실소유주로 간주되지 않으나, 여전히 규칙 13d-1(b)에 따른 보고 의무는 유지됩니다.

주식은 Karpus가 관리하는 재량 자문 계좌에 보유되어 있으며, Karpus는 모회사인 City of London Investment Group plc와는 독립적으로 정보 장벽을 통해 운영됩니다. 제출 서류는 해당 증권이 통상적인 사업 활동 중에 취득되었으며 발행사 지배권에 영향을 미치기 위한 목적이 아님을 확인합니다.

투자자에 대한 시사점: 이번 감소로 인해 EURKU의 공개 유통 주식 수가 소폭 증가하고 Karpus가 5% 이상의 주요 보유자 명단에서 제외되어 행동주의자 참여에 대한 기대가 다소 줄어들 수 있습니다. 그럼에도 불구하고 4.28%의 지분은 계속해서 의미 있는 소수 지분으로서 지속적인 기관 감시 역할을 할 수 있습니다.

Karpus Management, Inc. a déposé l'Amendement n° 2 au Schedule 13G concernant Eureka Acquisition Corp (EURKU) pour la date de l'événement du 30 juin 2025.

Le conseiller en investissement enregistré déclare désormais une possession bénéficiaire de 327 400 actions ordinaires, représentant 4,28 % de la classe en circulation. Karpus détient le pouvoir exclusif de vote et de disposition sur l'intégralité de la position et aucun pouvoir partagé avec d'autres parties. Comme la participation est passée sous le seuil de 5 %, Karpus n'est plus considéré comme un détenteur bénéficiaire de 5 % selon la Section 13(d) du Exchange Act, mais reste soumis aux obligations de déclaration de la Règle 13d-1(b).

Les actions sont détenues dans des comptes-conseils discrétionnaires gérés par Karpus, qui opère de manière indépendante de sa société mère, City of London Investment Group plc, grâce à des barrières informationnelles établies. Le dépôt confirme que les titres ont été acquis dans le cours normal des affaires et non dans le but d'influencer le contrôle de l'émetteur.

Implications pour les investisseurs : cette réduction augmente légèrement le flottant public d’EURKU et retire Karpus de la liste des détenteurs significatifs de 5 %, ce qui pourrait diminuer les attentes d’une implication activiste. Néanmoins, une position de 4,28 % reste une participation minoritaire significative pouvant assurer une surveillance institutionnelle continue.

Karpus Management, Inc. hat die Änderung Nr. 2 zum Schedule 13G für Eureka Acquisition Corp (EURKU) eingereicht, bezogen auf das Ereignisdatum 30. Juni 2025.

Der registrierte Anlageberater meldet nun wirtschaftliches Eigentum an 327.400 Stammaktien, was 4,28 % der ausstehenden Aktienklasse entspricht. Karpus hält alleinige Stimm- und Verfügungsgewalt über die gesamte Position und keine geteilte Macht mit anderen Parteien. Da der Anteil unter die 5%-Schwelle gefallen ist, gilt Karpus nicht mehr als 5%-Eigentümer nach Abschnitt 13(d) des Börsengesetzes, unterliegt jedoch weiterhin den Meldepflichten gemäß Regel 13d-1(b).

Die Aktien werden in diskretionären Beratungsdepots gehalten, die von Karpus verwaltet werden, das unabhängig von seiner Muttergesellschaft City of London Investment Group plc durch etablierte Informationsbarrieren operiert. Die Einreichung bestätigt, dass die Wertpapiere im normalen Geschäftsverlauf erworben wurden und nicht mit dem Ziel, die Kontrolle über den Emittenten zu beeinflussen.

Auswirkungen für Investoren: Die Reduzierung erhöht leicht den Streubesitz von EURKU und entfernt Karpus von der Liste bedeutender 5%-Anteilseigner, was die Erwartungen an aktivistische Eingriffe verringern könnte. Dennoch bleibt eine Position von 4,28 % ein bedeutendes Minderheitsinteresse, das eine fortlaufende institutionelle Überwachung ermöglichen kann.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Finn Patrick John

(Last) (First) (Middle)
C/O TWIST BIOSCIENCE CORPORATION
681 GATEWAY BLVD.

(Street)
SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Twist Bioscience Corp [ TWST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President and COO
3. Date of Earliest Transaction (Month/Day/Year)
07/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/02/2025 S 209(1) D $36.193 240,574 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Remarks:
/s/ Kendra Fox, as Attorney-in-Fact for Patrick John Finn 07/07/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Eureka Acquisition Corp (EURKU) shares does Karpus Management own?

Karpus reports beneficial ownership of 327,400 common shares.

What percentage of EURKU’s outstanding shares does this represent?

The stake equals 4.28 % of the outstanding common stock.

Does Karpus share voting or dispositive power over these shares?

No. The adviser holds sole voting and dispositive power and reports 0 % shared power.

Under which SEC rule is the Schedule 13G/A filed?

The filing is made pursuant to Rule 13d-1(b) for registered investment advisers.

What is the significance of falling below the 5 % ownership threshold?

Below 5 %, Karpus is no longer a statutory 5 % holder, reducing regulatory obligations and potential influence on control matters.
Twist Bioscience

NASDAQ:TWST

TWST Rankings

TWST Latest News

TWST Latest SEC Filings

TWST Stock Data

2.29B
58.73M
2.16%
112.29%
15.59%
Diagnostics & Research
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO